NOVARTIS AG CEDEAR EAC 4 REP 1(USD) financial statements, including revenue, expenses, and profit
The total revenue of NVSD for the last quarter is 12.71 B USD, and it's 3.08% lower compared to the previous quarter. The net income of Q4 24 is 2.72 B USD.